Angiostrongyliasis epidemiology and demographics

Revision as of 15:41, 10 August 2015 by Gerald Chi- (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Angiostrongyliasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiostrongyliasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Angiostrongyliasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiostrongyliasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiostrongyliasis epidemiology and demographics

CDC on Angiostrongyliasis epidemiology and demographics

Angiostrongyliasis epidemiology and demographics in the news

Blogs on Angiostrongyliasis epidemiology and demographics

Directions to Hospitals Treating Angiostrongyliasis

Risk calculators and risk factors for Angiostrongyliasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology

Following World War II, A. cantonensis spread throughout Southeast Asia and Western Pacific Islands including Australia, Melanesia, Micronesia, and Polynesia. Cases were soon reported in the following nations: New Caledonia, the Philippines, Rarotonga, Saipan, Sumatra, Taiwan and Tahiti. In the 1960s even more cases were reported from the region from locations such as: Cambodia, Guam, Hawaii, Java, Thailand, Sarawak, Vietnam and the New Hebrides (Vanuatu).[1]

In 1961, an epidemiological study of eosinophilic meningitis in humans was conducted by Rosen, Laigret, and Bories, who hypothesized that the parasite causing these infections was carried by fish. However Alicata noted that raw fish was consumed by large numbers of people in Hawaii without apparent consequences, and patients presenting with meningitis symptoms had a history of eating raw snails or prawns in the weeks before presenting with symptoms. This observation along with epidemiology and autopsy of infected brains confirmed A. cantonensis infection in humans as the cause of the majority of eosinophilic meningitis cases in Southeast Asia and the Pacific Islands.[2]

Since then, cases of A. cantonensis infestations have appeared in American Samoa, Australia, Hong Kong, Bombay, Fiji, Hawaii, Honshu, India, Kyushu, New Britain, Okinawa, Ryukyu Islands, Western Samoa and most recently mainland China. Other sporadic occurrences of the parasite in its rat hosts have been reported in Cuba, Egypt, Louisiana, Madagascar, Nigeria, New Orleans and Puerto Rico[1]

In recent years, the parasite has been shown to be proliferating at an alarming rate due to modern food consumption trends and global transportation of food products. Scientists are calling for a more thorough study of the epidemiology of A. cantonensis, stricter food safety policies, and the increase of knowledge on how to properly consume products commonly infested by the parasite.[3]

References

  1. 1.0 1.1 "EOSINOPHILIC MENINGITIS". Revised 28 February 2006, accessed 1 June 2011.
  2. Alicata J. E. (1991). "The Discovery of Angiostrongylus cantonensis as a Cause of Human Eosinophilic Meningitis". Parasitology Today 7(6): 151-153.
  3. Lv S., Zhang Y., Steinmann P. &, Zhou X.-N. (2008). "Emerging angiostrongyliasis in mainland China". Emerging Infectious Diseases 14(1): 161-164. HTM.